Nicotinic receptor stimulation protects neurons against β-amyloid toxicity

Annals of Neurology

Volumn 42, Issue 2, 1997, Pages 159-163

  Kihara, T ^a   Shimohama, S ^a   Sawada, H ^a   Kimura, J ^a   Kume, T ^a   Kochiyama, H ^a   Maeda, T ^a   Akaike, A ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; AMYLOID BETA PROTEIN; HEXAMETHONIUM; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; FETUS; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SENILE PLAQUE;

AMYLOID BETA-PROTEIN; ANIMALS; BENZYLIDENE COMPOUNDS; BUNGAROTOXINS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; FETUS; HEXAMETHONIUM; MECAMYLAMINE; NEURONS; NEUROPROTECTIVE AGENTS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PEPTIDE FRAGMENTS; PYRIDINES; RATS; RECEPTORS, NICOTINIC;

EID: 0030756236     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420205     Document Type: Article

References (36)

1. Perry G, Cras P, Siedlak SL, et al. Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am J Pathol 1992;140:283-290
2. Nelson PT, Marton L, Saper CB. Alz-50 immunohistochemistry in the normal sheep striatum: a light and electron microscope study. Brain Res 1993;600:285-297
3. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991;6:487-498
4. Hardy JA, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991;12:383-388
5. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256:184-185
6. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 1990;250:279-282
7. Loo DT, Copani A, Pike CJ, et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 1993;90:7951-7955
8. Gozes I, Bardea A, Reshef A, et al. Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc Natl Acad Sci USA 1996;93:427-432
9. Perry EK, Morris CM, Court JA, et al. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 1995;64:385-395
10. Shimohama S, Taniguchi T, Fujiwara M, et al. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J Neurochem 1986;46:288-293
11. Whitehouse PJ, Martino AM, Antuono PG, et al. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 1986;371:146-151
12. Akaike A, Tamura Y, Yokota T, et al. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 1994;644:181-187
13. Tamura Y, Sato Y, Akaike A, et al. Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 1992;592:317-325
14. Akaike A, Tamura Y, Sato Y, et al. Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity. Brain Res 1991;557:303-307
15. Shimohama S, Ogawa N, Tamura Y, et al. Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain Res 1993;632:296-302
16. Hunter BE, de Fiebre CM, Papke RL, et al. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci Lett 1994;168:130-134
17. Yankner BA, Dawes LR, Fisher S, et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989;245:417-429
18. Yankner BA, Caceres A, Duffy LK. Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci USA 1990;87:9020-9023
19. Roher AE, Lowenson JD, Clarke S, et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993;268:3072-3083
20. Pike CJ, Walencewicz AJ, Glabe CG, et al. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 1991;563:311-314
21. Sullivan JP, Decker MW, Donnelly RD, et al. Cholinergic channel activators: novel opportunities for the treatment of CNS disorders. Proc West Pharmacol Soc 1995;38:127-130
22. Gopalakrishnan M, Buisson B, Tourna E, et al. Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor. Eur J Pharmacol 1995;290:237-246
23. Marin P, Maus M, Desagher S, et al. Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuroreport 1994;5:1977-1980
24. Deneris ES, Connolly J, Rogers SW, et al. Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol Sci 1991;12:34-40
25. Seguela P, Wadiche J, Dineley MK, et al. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 1993;13:596-604
26. Couturier S, Bertrand D, Matter JM, et al. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron 1990;5:847-856
27. 125I]-alpha-bungarotoxin. J Neurosci 1985; 5:1307-1315
28. Martin EJ, Panicker KS, King MA, et al. Cytoprotective actions of 2,4-dimethoxybenzylidene anabaseine in differentiated PC-12 cells and septal cholinergic cells. Drug Dev Res 1994; 31:134-141
29. Treinin M, Chalfie M. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron 1995; 14:871-877
30. Zhang ZW, Vijayaraghavan S, Berg DK. Neuronal acetylcholine receptors that bind alpha-bungarotoxin with high affinity function as ligand-gated ion channels. Neuron 1994;12:167-177
31. 2+. Neuron 1992;8:353-362
32. Alkondon M, Reinhardt S, Lobron C, et al. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. II. The rundown and inward rectification of agonist-elicited whole-cell currents and identification of receptor subunits by in situ hybridization. J Pharmacol Exp Ther 1994;271:494-506
33. Shimohama S, Akaike A, Kimura J. Nicotine-induced protection against glutamate cytotoxicity: nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation. Ann NY Acad Sci 1996;777:356-361
34. Hu J, el Fakahany EE. Beta-amyloid 25-35 activates nitric oxide synthase in a neuronal clone. Neuroreport 1993;4:760-762
35. Le WD, Colom LV, Xie WJ, et al. Cell death induced by betaamyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res 1995;686:49-60
36. Behl C, Davis JB, Lesley R, et al. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994;77:817-827